Clari Vest Asset Management LLC Glycomimetics Inc Transaction History

Clari Vest Asset Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 09, 2021	SELL	$2.16 - $3.18 $364,608 - $536,784	-168,800 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$2.89 - $4.22 $112,132 - $163,736	38,800 Added 29.85%	168,800 $508,000
Q4 2020 Feb 09, 2021	SELL	$2.69 - $4.24 $5,111 - $8,056	-1,900 Reduced 1.44%	130,000 $489,000
Q3 2020 Nov 09, 2020	SELL	$3.07 - $5.0 $25,174 - $41,000	-8,200 Reduced 5.85%	131,900 $405,000
Q2 2020 Aug 12, 2020	BUY	$2.06 - $3.76 $288,606 - $526,776	140,100 New	140,100 $527,000

30.3M

51K

1.4K

Ticker GLYC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,423,900
Market Cap $15.2M
Description
GlycoMimetics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in the United States. It is developing uproleselan, an E-selectin inhibitor, which is used in combination with chemotherapy to treat acute myeloid leukemia (AML),...

Get notified when there are updates to the investment portfolio of Clari Vest Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Clari Vest Asset Management LLC with notifications on news.